Acute testosterone administration
US6428769B1 · kind B1 · utility
Assignees
Inventors
Key dates
| Filing date | May 2, 2000 |
| Grant date | Aug 6, 2002 |
| Priority date | — |
| Expiry date | May 2, 2020 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P15/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The libido of adult human female patients is increased by the intrapulmonary delivery of testosterone. A formulation of testosterone is aerosolized and inhaled into a patient's lungs where particles of testosterone deposits on lung tissue and then enter the patient's circulatory system. The patient's testosterone level is enhanced well above baseline levels for a short period and subsides to baseline levels with normal metabolism thereby providing desired short term effects on enhanced libido without undesirable effects of long term enhanced testosterone levels. Additional formulations are provided including formulations for aerosolized delivery of sildenafil citrate which are delivered to male or female patients.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.